HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. - Test2 - elhamkhani - TriplyDB

HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

http://www.wikidata.org/entity/Q34087997

about

The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover Regulation of immune cell function and differentiation by the NKG2D receptor NK Cells in HIV Disease Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo Evasion from NK cell-mediated immune responses by HIV-1 Immune surveillance of unhealthy cells by natural killer cells Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex Naturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmission Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.HIV-1 Vpr and G2 cell cycle arrest.Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.Copy number variation of KIR genes influences HIV-1 control.Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.Mechanisms of HIV-associated lymphocyte apoptosis: 2010 Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo NKG2D receptor regulates human effector T-cell cytokine production.CD4 mimetics sensitize HIV-1-infected cells to ADCC.Innate immunity in acute HIV-1 infection Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.HIV-1 Vpu interference with innate cell-mediated immune mechanisms.Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44 Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection DNA methylation in nasal epithelial cells from smokers: identification of ULBP3-related effects.NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.HIV-1 Vpr-a still "enigmatic multitasker".

P2860

Q21134793-625A39D1-722F-44A9-9940-961326F46957 Q24635093-F3308334-C468-459B-8782-E34ACD5A757D Q26752833-D0B8B0DD-779A-4C6C-85AF-EDF883983B98 Q26851152-E6A5C3E4-5BC8-4B70-ABD5-5C8A18ADD542 Q26864489-4E03626C-DEEE-4E92-8400-9B580F8DEA9D Q27003079-4C69F571-BE45-4ADD-A41A-E00C3906ABB7 Q27313676-4E3253DD-8E48-4326-AE8D-8864F534085F Q28237912-C041C612-59C2-43F9-8640-80F4E16DCD2F Q28727311-C9DCF1DC-00EB-44E7-8D0A-8D83244387D5 Q33759415-E779D144-AF55-4728-A9BA-6F54CA7F8874 Q33884000-BAE7CADD-F2B7-4C5B-9AB3-9773C216A8FE Q34037679-454DB1D2-BB39-461A-A0B0-791CB7457892 Q34090869-F5000D5F-10D7-495E-B65B-7FD41FAE438E Q34126743-D6AABFA4-4808-4472-BAC0-1521A0A9F53D Q34220186-DFD9970F-EE20-4CED-A133-D6B41AF339FB Q34402446-4CD42063-CE47-43D1-9670-7984EC0A222B Q34423336-7B515635-6628-487D-89E3-925E3E3768C9 Q34545417-94BFEEF0-9514-4134-8D05-4B6124D93129 Q34571277-64519D41-811F-4765-8386-C5C0673B614B Q34957142-48579694-1D65-4800-9246-73FEEF3FDC18 Q34992575-54B65C78-10C6-40EA-9F35-EFD768FA8E7C Q35067233-618BAE08-86DB-40B5-B4EF-C9A76CCA3486 Q35067621-2A648611-52E2-4D62-AD12-9E239A4E794F Q35644696-396A57B0-D2D2-483D-BAEF-66D555CDE30E Q35696991-C07C9D20-2246-4B1A-9A1D-8E643DF7E664 Q36086345-34328C78-77E0-4B70-AC08-007CB19A7D12 Q36141355-89DBA813-30F7-4A6C-A8A6-9AB8879771DC Q36484010-6B69DCE6-81B9-4674-9EE3-C6D9CA4BFCB8 Q36498061-6A062A6B-7C2F-4B78-8DCF-42D83057D0E8 Q36538762-24F883F2-1F7B-4362-AE2A-6EBC45231EFA Q36706005-F72FD4D6-EFC8-4A6B-B525-548403CD3E16 Q36736588-55024977-A532-4221-8DA2-A3641FAA3E8C Q37126033-63DD2C8B-73E5-4A07-BE10-2838DB9A9284 Q37147102-40872976-5A1E-4E4F-AB02-D1F0B0CA1313 Q37316220-3B8E130D-9F98-4687-BD47-A84DCF3DB8C6 Q37363561-3F7CEA71-B57C-43F3-88ED-BDE07FB21638 Q37598020-4A45F8B3-0FAA-4CF3-9540-4CE4A11912D6 Q37638959-06A4C187-A730-480D-95AB-BAFD2FECE049 Q37644079-38A3AD4B-635D-402A-9B7B-EA2CE41C7861 Q37689513-DCC14259-8FD6-4288-AF15-781280CE3C2F

P2860

HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

http://www.wikidata.org/entity/Q34087997

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@ast

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@en

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@nl

type

label

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@ast

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@en

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@nl

prefLabel

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@ast

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@en

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@nl

P1433

Q34087997-B5F2F19B-CA49-41F7-B142-D760D77DEA13

P1476

Q34087997-F3511619-E32C-44D3-A4DB-9199BC644853

P2093

Q34087997-354568EC-E55D-4345-A2E7-5FD36181716E

Q34087997-9432E8A4-2100-42F3-9799-0FF06EECC561

Q34087997-A059CD02-A331-4B9F-B43C-137D59F3B273

Q34087997-A2A38CAA-57FB-4F52-AADC-87A32225A426

Q34087997-F2F5F885-3C21-4372-9E8E-860AF36D1C2B

P2860

Q34087997-014CE42C-9F2B-4C58-A365-18AEABECBF10

Q34087997-04F0B900-162F-46AD-8B6C-7873EB9C5767

Q34087997-0C872D54-762F-4F72-B653-8B91454A7859

Q34087997-103848CA-E1DE-4102-AE6C-A926BF2CF8A2

Q34087997-10F15405-118D-4191-B7AF-78B48D5906B7

Q34087997-15C4CF79-14F3-4711-B804-E3B07B7A77F7

Q34087997-1EB16203-A61C-4E88-A8AC-FCDEF76A3F4D

Q34087997-20FEA929-C4FB-4819-BE43-9C1C17FD2648

Q34087997-220663E4-FA4F-47B8-AB47-F0894189EBAB

Q34087997-30130562-094B-4055-850B-889FDCA63323

P304

Q34087997-CE7222BB-9202-4BCC-93C4-8D0C9FB4807F

P31

Q34087997-F3BDDE02-CED1-4F7A-9D11-AE6CB3AA9573

P356

Q34087997-BE1C9893-AF46-42FF-87E7-A116DC757FAE

P407

Q34087997-9A7EF04E-5DAD-44A1-9A6F-82607084256F

P433

Q34087997-22ABE449-7F1B-4C7C-90B2-08F33C0DB894

P478

Q34087997-F958F1AE-54D0-4ACC-AE74-1AE0B255407D

P577

Q34087997-62E7F03B-3DA4-4E63-9F2A-53ED2859444C

P5875

Q34087997-F12E0325-A52E-425A-8966-E937E821DB69

P698

Q34087997-15189468-53BD-4CA8-BF79-A07BEF87A186

P932

Q34087997-64F7D349-713D-4C10-9AD1-F9B290B40B56

P356

BLOOD-2009-08-237370

P1433

P1476

HIV-1 Vpr up-regulates express ...... otes NK cell-mediated killing.

@en

P2093

Eric A Cohen

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Belzile

http://www.w3.org/2001/XMLSchema#string

Jonathan Richard

http://www.w3.org/2001/XMLSchema#string

Sardar Sindhu

http://www.w3.org/2001/XMLSchema#string

Tram N Q Pham

http://www.w3.org/2001/XMLSchema#string

P2860

HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest

Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle

HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

P304

1354-1363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-08-237370

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40686510

http://www.w3.org/2001/XMLSchema#string

P698

20008788

http://www.w3.org/2001/XMLSchema#string

P932

3955183

http://www.w3.org/2001/XMLSchema#string